Inactive Instrument
Sector dividends Caplin Point Laboratories Ltd NSE India S.E.
Stocks
INE475E01018
Pharmaceuticals
|
End-of-day quote
NSE India S.E.
|
||
| - INR | - |
|
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.9% | 1.05% | 35.04x | 4.91x | 6.58x | 22.81x | 27.6x | 48.26B | |
| 1.49% | 1.58% | 17.32x | 1.92x | 2.17x | 9.78x | 12.39x | 40.5B | |
| 0.94% | 1.06% | 26.96x | 2.98x | 3.27x | 16.93x | 21.73x | 11.85B | |
| 0.6% | 0.64% | 26.85x | 3.7x | 3.84x | 15.92x | 22.29x | 11.83B | |
| 3.76% | 3.85% | 19.17x | 3.32x | 3.41x | 11.88x | 14.14x | 9.36B | |
| 4.61% | 5.25% | 9.39x | 1.54x | 2.16x | 5.58x | 6.84x | 7.5B | |
| 3.19% | 3.16% | 15.79x | 1.31x | 2.07x | 6.88x | 9.62x | 7.37B | |
| 0.16% | 0.16% | 29.64x | 5.44x | 3.88x | 18.04x | 21.75x | 7.28B | |
| 0.96% | 1.11% | 34.49x | 7.99x | 6.73x | 24.57x | 27.12x | 4.58B | |
| 1.77% | 1.64% | 15.28x | 0.74x | 2.12x | 9.07x | 11.47x | 4.19B | |
| 3.62% | 4.11% | 14.51x | 2.43x | 2.41x | 10.8x | 10.63x | 3.81B | |
| 2.97% | 3.08% | 16.44x | 2.91x | 3.33x | 12.54x | 14.96x | 2.87B | |
| 3.05% | 3.45% | 19.81x | 5.03x | 5.65x | 16.95x | 18.54x | 2.56B | |
| Average | 2.16% | 2.32% | 21.59x | 3.40x | 3.66x | 13.98x | 16.85x | 12.46B | |
| Weighted average by Cap. | 1.6% | 1.73% | 24.62x | 3.43x | 4.04x | 15.39x | 18.96x |
Select your edition
All financial news and data tailored to specific country editions
